These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18245970)

  • 1. Topical bevacizumab and ocular surface neovascularization in patients with stevens-johnson syndrome.
    Uy HS; Chan PS; Ang RE
    Cornea; 2008 Jan; 27(1):70-3. PubMed ID: 18245970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of topical bevacizumab on corneal neovascularization.
    Kim SW; Ha BJ; Kim EK; Tchah H; Kim TI
    Ophthalmology; 2008 Jun; 115(6):e33-8. PubMed ID: 18439681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subconjunctival bevacizumab for corneal neovascularization.
    Zaki AA; Farid SF
    Acta Ophthalmol; 2010 Dec; 88(8):868-71. PubMed ID: 19519730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bevacizumab for corneal neovascularization.
    Jacobs DS; Lim M; Carrasquillo KG; Rosenthal P
    Ophthalmology; 2009 Mar; 116(3):592-3; author reply 593-4. PubMed ID: 19264217
    [No Abstract]   [Full Text] [Related]  

  • 5. Subconjunctival bevacizumab for corneal neovascularization.
    Doctor PP; Bhat PV; Foster CS
    Cornea; 2008 Oct; 27(9):992-5. PubMed ID: 18812760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bilateral response after unilateral subconjunctival bevacizumab injection in a child with Stevens-Johnson syndrome.
    Kesarwani S; Sahu SK; Basu S
    J AAPOS; 2012 Jun; 16(3):309-11. PubMed ID: 22459106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subconjunctival bevacizumab injection for corneal neovascularization in recurrent pterygium.
    Bahar I; Kaiserman I; McAllum P; Rootman D; Slomovic A
    Curr Eye Res; 2008 Jan; 33(1):23-8. PubMed ID: 18214740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effect of subconjunctival injection of bevacizumab in the treatment of corneal neovascularization.
    You IC; Kang IS; Lee SH; Yoon KC
    Acta Ophthalmol; 2009 Sep; 87(6):653-8. PubMed ID: 19021596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of subconjunctival bevacizumab on corneal neovascularization: results of a prospective study.
    Benayoun Y; Adenis JP; Casse G; Forte R; Robert PY
    Cornea; 2012 Aug; 31(8):937-44. PubMed ID: 22357391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of photodynamic therapy with verteporfin combined with intrastromal bevacizumab for corneal neovascularization in Stevens-Johnson syndrome.
    Yoon HJ; Kim MK; Seo KY; Ueta M; Yoon KC
    Int Ophthalmol; 2019 Jan; 39(1):55-62. PubMed ID: 29256167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subconjunctival and intracorneal bevacizumab injection for corneal neovascularization in lipid keratopathy.
    Oh JY; Kim MK; Wee WR
    Cornea; 2009 Oct; 28(9):1070-3. PubMed ID: 19724199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn.
    Yoeruek E; Ziemssen F; Henke-Fahle S; Tatar O; Tura A; Grisanti S; Bartz-Schmidt KU; Szurman P;
    Acta Ophthalmol; 2008 May; 86(3):322-8. PubMed ID: 17995975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined use of subconjunctival and intracorneal bevacizumab injection for corneal neovascularization.
    Yeung SN; Lichtinger A; Kim P; Amiran MD; Slomovic AR
    Cornea; 2011 Oct; 30(10):1110-4. PubMed ID: 21673570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angioregressive pretreatment of mature corneal blood vessels before keratoplasty: fine-needle vessel coagulation combined with anti-VEGFs.
    Koenig Y; Bock F; Kruse FE; Stock K; Cursiefen C
    Cornea; 2012 Aug; 31(8):887-92. PubMed ID: 22362005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perilimbal bevacizumab injection for interface neovascularization after deep anterior lamellar keratoplasty.
    Foroutan A; Fariba B; Pejman B; Mahmoud J; Khalil GF; Arash EA; Foroutan P
    Cornea; 2010 Nov; 29(11):1268-72. PubMed ID: 20802316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose topical bevacizumab for corneal neovascularization.
    Waisbourd M; Levinger E; Varssano D; Moisseiev E; Zayit-Soudri S; Barak A; Loewenstein A; Barequet I
    Pharmacology; 2013; 92(5-6):310-4. PubMed ID: 24335191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histologic findings of bevacizumab-treated human conjunctiva in Stevens-Johnson syndrome.
    Uy HS; Yu EN; Sua AS
    Cornea; 2011 Nov; 30(11):1273-6. PubMed ID: 21941176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subconjunctival bevacizumab injection for corneal neovascularization.
    Bahar I; Kaiserman I; McAllum P; Rootman D; Slomovic A
    Cornea; 2008 Feb; 27(2):142-7. PubMed ID: 18216566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Subconjunctival bevacizumab for corneal neovascularization].
    Gueudry J; Richez F; Tougeron-Brousseau B; Genevois O; Muraine M
    J Fr Ophtalmol; 2010 Nov; 33(9):630-6. PubMed ID: 21035899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy.
    Avery RL; Pearlman J; Pieramici DJ; Rabena MD; Castellarin AA; Nasir MA; Giust MJ; Wendel R; Patel A
    Ophthalmology; 2006 Oct; 113(10):1695.e1-15. PubMed ID: 17011951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.